Discussion of FDA Guidance Regarding COVID-19

– One of the soft skills that I discussed last week, is the importance of being able to adapt to change. There is an example now causing so many changes, affecting all areas of the clinical research industry, COVID-19 (Coronavirus Disease 2019). The FDA recognizes that this pandemic is going to impact the conduct of clinical trials, and recently issued a guidance document for industry, investigators, and Institutional Review Boards regarding the conduct of clinical trials of medical products during the COVID-19 pandemic. Join me, as I review and discuss this guidance document and its recommendations for clinical trials.

You can listen to Discussion of FDA Guidance Regarding COVID-19 online on Radio and Podcast. Open the player on this page to stream the available audio.

Discussion of FDA Guidance Regarding COVID-19 is an episode from Let's Get Clinical, Tips From The CRA Helper by Elizabeth.

This episode is 16:04 long.

This episode was published on Apr 3, 2020.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Let's Get Clinical, Tips From The CRA Helper when more episodes are available from the podcast feed.